Intestinal nontuberculous mycobacteria infection: A case report

Author:

Xu Yanbin1,Yang Jinfeng1,Cui Lili1,Huang Chengchen2,Wu Chun1ORCID

Affiliation:

1. Department of Multidrug Resistant Tuberculosis, Changchun Infectious Disease Hospital, Changchun, China

2. Department of Medical Affairs, Shanghai Conlight Medical Laboratory Co., Ltd, Shanghai, China.

Abstract

Background: Intestinal nontuberculous mycobacteriosis due to nontuberculous mycobacteria infection has clinical manifestations similar to intestinal tuberculosis and inflammatory bowel disease, causing difficulties in clinical diagnosis. Case presentation: A 42-year-old male patient was admitted to the Sino-Japanese Friendship Hospital of Jilin University in June 2021 for diarrhea and intermittent hematochezia since April 2021. He was diagnosed with inflammatory intestinal disease by colonoscopy and midtransverse colon biopsy. However, the symptoms did not relieve after 2 months of mesalazine treatment. In August 2021, the patient was admitted to the outpatient department for suspected “intestinal tuberculosis.” A diagnosis of intestinal nontuberculous mycobacteriosis was confirmed based on pathology and nucleotide-based matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS). After 2 weeks of antimycobacterial therapy, the patient’s diarrhea was relieved, and hematochezia no longer appeared. In November 2021, recolonoscopy revealed scattered erosions and ulcers in ileocecal valve and ascending colon, while both nucleotide-based MALDI-TOF MS and next-generation sequencing could still detect Mycobacterium intracellulare. Conclusion: This study reported a patient with an intestinal nontuberculous mycobacteriosis diagnosed by colonoscopy biopsy and nucleotide-based MALDI-TOF MS, and symptoms were relieved after antimycobacterial treatment.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference20 articles.

1. Editorial Board of “Chinese Journal of Tuberculosis and Respiratory Medicine,” expert consensus on diagnosis and treatment of non-tuberculous mycobacterial disease.;Chin J Tubere Respir Dis,2012

2. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline.;Daley;Eur Respir J,2020

3. British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).;Haworth;Thorax,2017

4. Guidelines for the diagnosis and treatment of non-tuberculous mycobacteriosis (2020 edition).;Chin J Tuber Respir Dis,2020

5. Matrix-assisted laser desorption/ionization time of flight mass spectrometry (MALDI-TOF MS) analysis for the identification of pathogenic microorganisms: a review.;Chen;Microorganisms,2021

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Mesalazine;Reactions Weekly;2024-04-13

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3